期刊文献+

链脲佐菌素致阿尔茨海默病模型大鼠脑内mTOR/P70S6K/IRS-1信号通路的变化 被引量:1

Change of m TOR/P70S6K/IRS-1 signaling pathway in the brain of Alzheimer's disease rats induced by streptozotocin
下载PDF
导出
摘要 目的:观察侧脑室(intracerebroventricular,ICV)注射链脲佐菌素(streptozotocin,STZ)对大鼠脑内m TOR/P70S6K/IRS-1信号通路的影响。方法:将30只雄性SD大鼠随机分为对照组和模型组,每组各15只,对照组于第1天和第3天ICV注射生理盐水,模型组于第1天和第3天侧脑室注射STZ(ICV-STZ,3 mg/kg)建立AD模型。第1次注射后36 d采用Morris水迷宫检测2组大鼠空间学习和记忆能力的变化;Western blot检测2组大鼠大脑皮质和海马组织哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,m TOR)、磷酸化哺乳动物雷帕霉素靶蛋白(phosphorylated mammalian target of rapamycin,p-m TORSer2448)、核糖体40S小亚基S6蛋白激酶(P70 ribosomal S6 protein kinase,P70S6K)、磷酸化核糖体40S小亚基S6蛋白激酶(phosphorylated P70 ribosomal S6 protein kinase,p-P70S6KThr389)、胰岛素受体底物-1(insulin receptor substract-1,IRS-1)和磷酸化胰岛素受体底物-1(phosphorylated insulin receptor substract-1,p-IRS-1Ser636)蛋白的表达;HE染色观察2组大鼠大脑皮质和海马组织形态学的改变;甲硫素S染色观察2组大鼠脑内Aβ的沉积。结果:Morris水迷宫结果显示ICV-STZ能明显降低大鼠目标象限停留时间[对照组:(55.945±9.447)s,模型组:(31.961±5.346)s,t=8.558,P=0.000]和穿越平台次数[对照组:(7.533±2.560)次,模型组:(2.867±1.506)次,t=6.086,P=0.000];HE染色可见:ICV-STZ大鼠大脑皮质和海马的部分细胞出现了明显的固缩和肿胀;甲硫素S染色发现:在ICV-STZ处理后,大鼠脑内出现Aβ的大量沉积。Western blot结果表明:ICV-STZ能同时增加大鼠大脑皮质p-P70S6KThr389[对照组:(0.268±0.066),模型组:(0.654±0.079),t=-8.409,P=0.000]、p-IRS-1Ser636[对照组:(0.710±0.092),模型组:(1.033±0.135),t=-4.417,P=0.002]和海马p-P70S6KThr389[对照组:(0.405±0.064),模型组:(0.732±0.077),t=-7.339,P=0.000]、p-IRS-1Ser636[对照组:(0.498±0.093),模型组:(0.836±0.102),t=-5.496,P=0.001]蛋白的表达,但不影响大鼠大脑皮质和海马P70S6K、m TOR、p-m TORSer2448、IRS-1蛋白的表达。结论:ICV-STZ能增加大鼠脑内m TOR/P70S6K/IRS-1信号通路的激活,提示异常活化的m TOR/P70S6K/IRS-1信号通路可能参与了AD的发生发展。 Objective:To investigate the effects of intracerebroventricular injection of streptozotocin on m TOR/P70S6K/IRS-1 signaling pathway. Methods:The 30 male SD rats were randomly divided into control group and model group,fifteen rats in each group. The rats were treated with saline or streptozotocin(STZ,3 mg/kg)intracerebroventricularly(ICV)at the 1st day and the 3rd day of the experiment to induce dementia model. Thirty-six days after STZ injection,spatial learning and memory of the rats were determined by Morris water maze test. The expression of mammalian target of rapamycin(m TOR),phosphorylated m TOR(p-m TORSer2448),p70 ribosomal S6 protein kinase(P70S6K),phosphorylated P70S6K(p- P70S6KThr389),insulin receptor substract- 1(IRS-1)and phosphorylated IRS-1(p-IRS-1Ser636)were measured by Western blot. Morphologic changes of neurons in cerebral cortex and hippocampus were observed by HE staining. Deposition of Aβ in hippocampus was detected by Thioflavin S staining.Results:ICV-STZ can significantly reduce the time spent in the target quadrant(t=8.558,P=0.000)and numbers of platform location crosses(t=6.086,P=0.000). HE staining demonstrated that some cells were clearly shrank and swelled in cerebral cortex and hippocampus of rats treated by STZ. Meanwhile,the deposition of Aβ detected by Thio-flavin S staining was also significantly increased.Compared with that in control group,the expressions of p-P70S6KThr389(t =-8.409,P=0.000),p-IRS-1Ser636(t=-4.417,P=0.002)in the cerebral cortex and p-P70S6KThr389(t=-7.339,P=0.000),p-IRS-1Ser636(t=-5.496,P=0.001)in hippocampus were increased markedly,while the protein levels of P70S6 K,m TOR,p-m TORSer2448 and IRS-1 were not affected by ICV- STZ. Conclusion:ICVSTZ results in increased activation of m TOR/P70S6K/IRS-1 signaling pathway,and the increased activation of m TOR/P70S6K/IRS-1may play important roles in AD pathogenesis.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2015年第5期687-692,共6页 Journal of Chongqing Medical University
基金 重庆市科委前沿与应用基础研究资助项目(编号:cstc2014jcyj A10014) 重庆市教委科学技术研究资助项目(编号:KJ130320)
关键词 阿尔茨海默病 哺乳动物雷帕霉素靶蛋白 核糖体40S小亚基S6蛋白激酶 胰岛素受体底物-1 Alzheimer's disease mammalian target of rapamycin p70 ribosomal S6 protein kinase insulin receptor substract-1
  • 相关文献

参考文献18

  • 1Spilman P,Podlutskaya N,Hart MJ,et al.Inhibition of mTOR byrapamycin abolishes cognitive deficits and reduces amyloid-beta levelsin a mouse model of Alzheimer’s disease[J].PLoS One,2010,5(4):e9979.
  • 2Orr ME,Salinas A,Buffenstein R,et al.Mammalian target of ra-pamycin hyperactivity mediates the detrimental effects of a high sucrosediet on Alzheimer’s disease pathology[J].Neurobiol Aging,2014,35(6):1233-1242.
  • 3Li X, Alafuzoff I,Soininen H,et al.Levels of mTOR and its down-stream targets 4E -BP1, eEF2, and eEF2 kinase in relationships withtau in Alzheimer’s disease brain[J].FEBS J,2005,272(16):4211-4220.
  • 4Lafay-Chebassier C, Paccalin M, Page G,et al.mTOR/p70S6k sig-nalling alteration by Abeta exposure as well as in APP-PS1 transgenicmodels and in patients with Alzheimer * s disease[J]J Neurochem, 2005,94(l);215-225.
  • 5Caccamo A,Majumder S,Richardson A,et al.Molecular interplaybetween mammalian target of rapamycin (mTOR ) , amyloid -beta, andTau:effects on cognitive impairments[J].J Biol Chem,2010,285(17):13107-13120.
  • 6Shang YC,Chong ZZ,Wang S,et al.Prevention of p -amyloid de-generation of microglia by erythropoietin depends on Wntl ,the PI 3-K/mTOR pathway, Bad, and Bcl-xL[J].Aging (Albany NY) ,2012,4(3):187-201.
  • 7Ma T, Hoeffer CA, Capetillo -Zarate E,et al.Dysregulation of themTOR pathway mediates impairment of synaptic plasticity in a mousemodel of Alzheimer’s disease[J].PLoS 0ne,2010,5(9) :el2845.
  • 8Um SH,Frigerio F, Watanabe M,et al.Absence of S6K1 protects a-gainst age- and diet-induced obesity while enhancing insulin sensitivi-ty[J].Nature,2004,431(7005 ) : 200-205.
  • 9Moloney AM, Griffin RJ, Timmons S,et al.Defects in IGF-1 recep-tor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possi-ble resistance to IGF-1 and insulin signaling[J].Neurobiol Aging,2010,31(2):224-243.
  • 10杨文青,马晶,刘争,芦永良,余华荣.侧脑室注射链脲佐菌素致大鼠脑内胰岛素通路障碍和认知水平降低[J].中国病理生理杂志,2013,29(3):462-468. 被引量:8

二级参考文献1

共引文献7

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部